Drug recall D-0597-2018
Product
Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Hospira, Inc., Lake forest, IL 60045 USA. NDC: 0409-2634-01
Reason for recall
Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.
Lots and codes
Lot 71330DD EXP. 11/1/2018.
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 29, 680 vials
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- February 7, 2018
- Terminated
- August 7, 2019
Related products
- Hydromorphone Hydrochloride – drug information
- NDC 0409-2634 Hydromorphone Hydrochloride · Hydromorphone Hydrochloride 10 mg/mL · Hospira, Inc.